Published: Apr, 2018

The global cytology and HPV testing market has a handful of players whose moves control the dynamics of the market. Hence, the market is largely oligopolistic in nature and the actions of each of the market players is expected to invite a response from other players. Furthermore, each market player is wary of the business innovations and latest developments made by its counterparts, which reflects the sensitivity of the competitive landscape. The level of competition is moderate because the leading players do not engage in a rat race for market share and focus on retaining their current position in the market through collective efforts. Moreover, the strongholds of the leading players do not allow new entrants to establish themselves in the market, which further brings down the bar of competition. Hologic, Inc., F.Hoffman-La Roche AG,  and Qiagen N.V. are the top three players in the global market for cytology and HPV testing, and they account for 86% of the total market share. Considering the adroitness of these players with business strategies, it is projected that they will continue to dominate the market over the coming years.

Transparency Market Research (TMR) ran an analytic drill to understand the dynamics of the global market for cytology and HPV testing. The market value in the year 2015 was US$7.9 bn and is projected to settle at a value of US$10.5 bn 2024-end. The market would expand at a sluggish CAGR of 2.9% over the forecast period from 2016 to 2024, and hence, no significant growth in revenues could be expected over the given course of time. Based on geography, North America is anticipated to register a CAGR of 3.30%, which is prophesized to be greater than the growth rate of all other regional segments.

cytology-and-hpv-testingNeed for Cancer Diagnostics to Propel Demand

Cell testing and analysis has held immense utility for the medical and healthcare sector due to the diverse applications of cell culture. This has played a crucial role in bringing cytology testing to the fore over the past years. The rising incidence of various types of cancers has compelled healthcare experts to engage in core research and development in the field of oncology. This has also given a boost to the demand for cytology and HPV testing and has created growth spaces for market vendors. The need for early diagnostics is another factors that is expected to propel demand within the global market. Despite the aforementioned market drivers, the growth of the market for cytology and HPV testing could be hampered by the lack of awareness about cytology testing in certain regional pockets.

North America Dominates Global Market

The high incidence of cervical cancer coupled with the rising awareness about cytology testing in North America has propelled demand within the regional market. The government along with several private organizations has aided the domain of cytology and HPV testing, which has further enhanced the prospects of growth in North America. In Asia Pacific, the availability of cheap labor is expected to contribute to the growth of the regional market.

The review is based on a report by TMR tiled, “Cytology and HPV Testing Market (Product and Services - Cytology Testing (Systems, Assay Kits, Services), HPV Testing - Systems, Assay Kits, Services) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 – 2024”

The global market can be segmented based on the following parameters:

Global Cytology and HPV Testing Market, by Product and Services

  • Cytology Testing
    • Systems
    • Assay Kits
    • Services
  • HPV Testing
    • Systems
    • Assay Kits
    • Services

Global Cytology and HPV Testing Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • Australia
    • Rest of APAC
  • Rest of the World (RoW)
    • Brazil
    • Mexico
    • Rest of RoW

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com